Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DTC Smartphone Ads Present An “Interesting” Problem For DDMAC

Executive Summary

Add another electronic advertising vehicle to DDMAC’s growing list of potentially problematic DTC media that it must regulate: mobile device promotion.

You may also be interested in...

DTC Safety Messages Could Vary By Platform As FDA Considers Screen Size

Both tablets and huge TVs have proliferated since the last research of the impact of superimposed text.

Copaxone Promos Can’t List Risks Product Doesn’t Have, Especially Incorrectly, FDA Warns

The first warning letter of the year from FDA’s Office of Prescription Drug Promotion goes to Teva for web pages and materials displayed at a medical conference that overstated the safety and efficacy of its MS drug Copaxone.

Can Pfizer’s "Virtual Trial" Change The Game, Cut Development Costs?

As drug makers seek ways to reduce the cost of clinical trials, Pfizer thinks the solution could be asking patients to reach into their own pockets – for their cell phones.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts